Genotyping Influences Outcome of Coronary Artery Stenting

NCT02707445 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

5000

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Ischemia
CLOPIDOGREL, POOR METABOLISM of (Disorder)

Interventions

DRUG: Clopidogrel

Sponsor

Korea University Anam Hospital